37 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
, social and governance (ESG) initiatives that may benefit the patients we aspire to serve, in a manner that aligns with our organizational culture, core
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
number, e-mail address, photograph, social security number or tax identification number, driver’s license
number, passport number, credit card number
424B3
tus yppjhpw4v4t5j
8 Aug 22
Prospectus supplement
5:47pm
S-4
zdza adr0
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
de9kqykg8
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
0tn 02mvrmwa3m
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-1.1
kwqj7epo31 ls
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm